Recorded Presentation from the NCCN Pharmacy Updates: Palliative Care for Patients with Cancer - Symptom Management for Pain and Dyspnea
Pharmacists can play a critical role in patient education, therapy recommendations, and therapy management in palliative care and should be familiar with appropriate pharmacologic interventions for symptom management.
Category
  • Palliative Care
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Best Practices for Transitioning Oncology Therapies from the Inpatient to the Outpatient Setting
It is important for pharmacists to be familiar with the steps that are involved in transitioning oncology therapies that have been historically provided in an inpatient setting to the outpatient setting, and be familiar with the criteria for successful implementation of such an initiative.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: Advances in the Management of Gastrointestinal Stromal Tumors (GIST) and Other Soft Tissue Sarcomas
Continued education for oncology care providers is necessary to convey updates in the management of STS and improve patient outcomes.
Category
  • Soft Tissue Sarcomas
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Infection Concerns with Emerging Immune-targeted Treatments in Immunocompromised Patients with Cancer
Although the toxicity profiles of the newer molecularly targeted drugs are less focused on blood cells than those of traditional cytotoxic therapies, there are still infectious risks; safety and efficacy can only be guaranteed by multidisciplinary teams that have therapeutic expertise in the pharmacology of oral anti-cancer therapy.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: Updates in the Management of Pancreatic Cancer
Continued education regarding the management of pancreatic cancer is required to bridge the gap in cancer care and improve outcomes in the patient population.
Category
  • Pancreatic Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: The Evolving Landscape of Maintenance Therapy for Ovarian Cancer
This webinar will discuss key concepts in maintenance therapy for ovarian cancer, review clinical efficacy and safety data on potential treatment options and identify and address special considerations for monitoring and patient/caregiver education.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Current Challenges with Investigational Drug Services and Expanded Access Programs
It is necessary to identify the practice gaps in investigational drug services and provide solutions for better process improvement in managing clinical trials. In addition, it is important for pharmacists to be familiar with the steps that are involved in initiating expanded access programs and determine the criteria for successful enrollment and implementation of such programs.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Understanding the Place in Therapy for an Oral LHRH Antagonist as a Treatment Option in Prostate Cancer
Relugolix has a unique place in therapy for the treatment of prostate cancer. As a first-in-class oral LHRH antagonist, relugolix provides many benefits for patients. However, it is critical to understand how to manage the potential toxicities, drug interactions and adherence issues when initiating and maintaining this new oral agent.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Not Just a Band-Aid: The Impact of Chemotherapy Dose Banding in Infants
It is important for health care professionals caring for pediatric patients with cancer to identify challenges in chemotherapy dosing for infants and smaller children, rationales for current dosing recommendations commonly utilized in clinical trials, and the potential impact of BSA-based dose banding in this specific subset of the pediatric patient population.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Crossroads of Exercise and Chemotherapy
It is important to provide education and an action plan to outline how exercise may not only reduce side effects from chemotherapy but also help chemotherapy work better and improve survival. As new data emerges, more specific exercise “doses” can be prescribed.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages